Model for End‐Stage Liver Disease Is a Novel Potential Predictor of 30‐Day Mortality in Patients With Necrotizing Fasciitis
International Journal of Dermatology · 2026
DOI: 10.1111/ijd.70044 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Journal of Dermatology, 2026. Verfasst von Thilo Gambichler und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Klinikum Dortmund gGmbH, University Witten/Herdecke, Dortmund, Germany. Hauptthemen laut MEDLINE: Fasciitis, Necrotizing, End Stage Liver Disease. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Background
Necrotizing fasciitis (NF) is a rapidly progressive soft‐tissue infection with high morbidity and mortality. Early identification of patients at risk for ICU admission and 30‐day mortality is critical.
Methods
In this multicenter cohort study, 88 NF patients were compared with age‐ and gender‐matched erysipelas controls. We studied systemic immune‐inflammation biomarkers (e.g., SII, NLR), the model for end‐stage liver disease (MELD; calculated from serum bilirubin, creatinine, and INR), kidney markers, and the LRINEC score at presentation. Logistic regression identified ICU admission predictors; Cox regression assessed 30‐day mortality.
Results
Compared with erysipelas controls, NF patients had higher white‐cell counts, liver enzymes, creatinine, CRP, and procalcitonin; only MELD differed among composite indices ( p < 0.01). Of 88 NF cases, 58 (65.9%) required ICU care and 21 (23.9%) died within 30 days. Univariable analysis linked ICU admission to CRP > 295.3 mg/L, sepsis, trunk involvement, no upper‐extremity infection, and higher LRINEC (all p < 0.01). Thirty‐day mortality correlated with younger age, dementia, severe liver disease, eosinopenia, and elevated MELD, INR, and creatinine (all p < 0.05). Multivariable models showed CRP > 295.3 mg/L (OR 42.5; 95% CI 4.3–424.4) and sepsis (OR 13.5; 95% CI 3.3–32.8) as independent ICU admission predictors, and MELD score alone predicted 30‐day mortality (HR 1.61 per point; 95% CI 1.13–2.30).
Conclusions
High CRP levels confirm their value in predicting ICU admission; however, the most novel finding is the independent prognostic power of MELD for 30‐day mortality. Incorporating MELD alongside CRP into clinical pathways could markedly improve early risk stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Klinikum Dortmund gGmbH, University Witten/Herdecke, Dortmund, Germany.
- Department of Dermatology, Ruhr-University Bochum, Bochum, Germany.
- Department of Dermatology, Christian Hospital Unna, Unna, Germany.
- Department of Dermatology, Helios St. Johannes Hospital Duisburg, Duisburg, Germany.
- Department of Dermatology, Helios St. Elisabeth Hospital Oberhausen, University Witten/Herdecke, Oberhausen, Germany.
ORCID-Profile: Thilo Gambichler
Zitieren
APA
Gambichler, T., Rasched, N. A., Susok, L., Kreuter, A., & Abu Rached, N. (2026). Model for End‐Stage Liver Disease Is a Novel Potential Predictor of 30‐Day Mortality in Patients With Necrotizing Fasciitis. International Journal of Dermatology. https://doi.org/10.1111/ijd.70044
Vancouver
Gambichler T, Rasched NA, Susok L, Kreuter A, Abu Rached N. Model for End‐Stage Liver Disease Is a Novel Potential Predictor of 30‐Day Mortality in Patients With Necrotizing Fasciitis. International Journal of Dermatology. 2026. doi:10.1111/ijd.70044
BibTeX
@article{Gambichler2026,
author = {Gambichler, Thilo and Rasched, Nesrien Abou and Susok, Laura and Kreuter, Alexander and Abu Rached, Nessr},
title = {Model for End‐Stage Liver Disease Is a Novel Potential Predictor of 30‐Day Mortality in Patients With Necrotizing Fasciitis},
journal = {International Journal of Dermatology},
year = {2026},
doi = {10.1111/ijd.70044}
}
EUVIMED